Investigating brain stimulation effects on memory in older adults with mild cognitive impairment
Official title: A Mechanistic Study to Investigate tDCS and Working Memory in MCI Patients
Run by University of Florida · NCT05998031 · Data updated 2026-11-12
This study is testing if a type of brain stimulation can help improve memory in older adults with mild cognitive impairment compared to those without memory issues.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 60 Years to 95 Years |
| Sex | All |
| Enrollment | 110 (estimated) |
| Sponsor | University of Florida Academic / other |
| Locations | 1 site (Gainesville, Florida) |
| Status | Recruiting |
| Started | April 24, 2024 |
| Main results expected | November 30, 2029 |
| Study ends | November 30, 2029 |
| Registry record updated | June 26, 2026 |
| Trial ID | NCT05998031 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates are older adults aged 60-95 with mild cognitive impairment and a Montreal Cognitive Assessment score of 18 or above.
✕Probably not a fit
Patients with contraindications to MRI or those with neurological disorders, psychiatric conditions, or significant medical issues may not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This study evaluates the effects of transcranial direct current stimulation (tDCS) on working memory in older adults with mild cognitive impairments (MCI) compared to cognitively healthy individuals. It employs a crossover design with both active and sham stimulation, enrolling 110 participants aged 60-95. The study utilizes multi-modal neuroimaging and computational modeling to assess changes in cognitive function and brain structure. The goal is to understand how tDCS can enhance neural plasticity and improve working memory performance.
Why it matters
Potential benefit: If successful, this study could lead to new non-invasive treatments for improving memory in older adults with cognitive impairments.
How similar studies have gone: Previous studies have shown promise in using tDCS for cognitive enhancement, suggesting potential success for this approach.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria * Age 60-95 years * Montreal Cognitive Assessment (MoCA) score 18 and above (scores will be adjusted for education) * Able to receive electrical stimulation * Ability to comprehend conversational voices * Adequate motor capacity to operate computer mouse and click-button in-scanner * Ability to participate in the intervention and attend training sessions Exclusion Criteria * Failure to provide informed consent * Contraindications to MRI recording (e.g., any kind of ferrous metallic stents or ferrous metal objects in the body, heart valve prosthesis, or other metal implants, claustrophobia, neurostimulation system, defibrillator, pacemaker, or other implanted device) * Left-handed, or left hand dominant * History of neurological, seizures, and psychiatric disorders, traumatic brain injury, incidence of stroke involving large vessel * Terminal illness with life expectancy less than 12 months, as determined by physician * Brain tumor or malformation or any foreign body known or previously identified in brain * Cancer in active treatment, besides skin cancer * Currently on GABAergic or glutamatergic medications, or on calcium or sodium channel blockers, which alter or block the ability of tDCS to facilitate tissue excitability * Unable to communicate because of severe hearing loss or speech disorder * Severe sensory impairment * Inability to communicate in English * Severe visual impairment, which would preclude completion of the assessment and/or intervention * No physical impairment precluding motor response or lying still for an hour in the scanner that could confound study findings * Moderate-to-severe depressive symptoms as defined by scoring 10 or above on the Geriatric Depression Scale (GDS)
Where it's running
-
University of Florida
Gainesville, Florida, United States Recruiting
Study contacts
- Principal investigator: Aprinda I Queen, PhD — University of Florida
- Study coordinator: Aprinda I Queen, PhD
- Email: aimstudy@phhp.ufl.edu
- Phone: 3522948990
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Accelerated rTMS for Cognitive Function in adults with mild to moderate cognitive impairment
This study tests whether a short course of accelerated rTMS with the EXOMIND device can improve thinking skills in adults ages 50–90 with mild cognitive impairment or mild dementia.
-
Cognitive screening and multidomain care to slow memory and thinking decline in older adults with type 2 diabetes
This study will test whether regular cognitive screening plus a two-year program of medication optimization, adjusted HbA1c targets, vascular risk management, lifestyle changes, and social support can slow cognitive decline in people aged 65 and older with type 2 diabetes.
-
Making cognitive screening easy for primary care providers
This project will test an automated Spanish‑language risk assessment and brief iPad cognitive screen to help primary care teams find early memory and thinking problems in people aged 60 and older.
-
Memantine plus structured exercise to protect thinking and memory during breast cancer chemotherapy
This will test whether memantine combined with a supervised exercise program, memantine alone, or a placebo can prevent or reduce thinking and memory problems in people receiving chemotherapy for stage I–III breast cancer.
-
Effects of different anesthesia techniques on cognitive function in elderly hip fracture patients
This study tests different anesthesia methods to see which one helps older patients with hip fractures keep their thinking skills sharp during and after surgery.
-
Combining sleep promotion and cognitive training to improve brain function in older ICU survivors
This study is testing if helping older adults who survived ICU treatment sleep better and do brain exercises can improve their thinking skills.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.